BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Jan 03, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Lorcaserin regulatory update

Arena announced plans to resubmit an NDA for obesity candidate lorcaserin by the end of 2011 after meeting with FDA to discuss issues outlined in an October complete response letter, including mammary tumors and brain astrocytomas seen...

Read the full 165 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >